| Product Name | Therapeutic Area | Preclinical | Phase 1 | Phase 2 | Phase 3 | Approved | Details |
|---|---|---|---|---|---|---|---|
| Insulin | Diabetes | Read More | |||||
|
Development of insulin produced in human cells has been initiated through CRO. |
|||||||
| Interferon-α/β | Multiple Sclerosis, Cancer & Viral Infections | Read More | |||||
|
Development of interferon products expressed in human cells has been initiated through CRO. |
|||||||
| Erythropoietin | Anemia, Cancer Kidney Failure | Read More | |||||
|
Development of erythropoietin espressed in human cells has been initiated through CRO. |
|||||||
| SARS-CoV2 | Vaccine | Read More | |||||
|
Development of the SARS-CoV2 vaccine as a subunit protein antigen expressed in insect cells has been initiated through CRO. |
|||||||
| SARS-CoV2 | Small Molecule | Read More | |||||
|
Project plans being developed, work will be initiated through CRO. |
|||||||
| HIV | Small Molecule | Read More | |||||
|
Project plans being developed, work will be initiated through CRO. |
|||||||
| Product Name | Therapeutic Area | Preclinical | Phase 1 | Phase 2 | Phase 3 | Approved | Details | Factor VIII | Hemophilia-A | Read More |
|---|---|---|---|---|---|---|---|
|
Construct design completed. Program plans being developed, Work will be initiated through CRO. |
|||||||
| Factor X | Hemophilia-B | Read More | |||||
|
Construct design completed. |
|||||||
| Follicle-stimulating hormone(FSH) | Infertility | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Granulocyte Colony Stimulating Factor (G-CSF) | Cancer, Hematopoietic Stem Cell Transplantation, HIV/AIDS Neutropenia | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Luteinizing hormone (LH) | Infertility | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Human chorionic gonadotropin (hCG) | Infertility | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Streptokinase | Stroke | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Tissue Plasminogen Activator (tPA) | Stroke | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Antibody | Cancer | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Antibody | Inflammation | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Hepatitis-B | Small Molecule | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Hepatitis – B | Vaccine | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Malaria | Small Molecule | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Malaria | Vaccine | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Cervical cancer-HPV | Vaccine | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Yellow Fever | Vaccine | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Ebola | Vaccine | Read More | |||||
|
Construct design completed. Program plans being developed. |
|||||||
| Product Name: | Insulin | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic Area: | Diabetes | ||||||||
| Status: |
|
||||||||
|
Development of insulin produced in human cells has been initiated through CRO. |
|||||||||
| Product Name: | Interferon-α/β | ||||||||
| Therapeutic Area: | Multiple Sclerosis, Cancer & Viral Infections | ||||||||
| Status: |
|
||||||||
|
Development of interferon products expressed in human cells has been initiated through CRO. |
|||||||||
| Product Name: | Erythropoietin | ||||||||
| Therapeutic Area: | Anemia, Cancer Kidney Failure | ||||||||
| Status: |
|
||||||||
|
Development of erythropoietin espressed in human cells has been initiated through CRO. |
|||||||||
| Product Name: | SARS-CoV2 | ||||||||
| Therapeutic Area: | Vaccine | ||||||||
| Status: |
|
||||||||
|
Development of the SARS-CoV2 vaccine as a subunit protein antigen expressed in insect cells has been initiated through CRO. |
|||||||||
| Product Name: | SARS-CoV2 | ||||||||
| Therapeutic Area: | Small Molecule | ||||||||
| Status: |
|
||||||||
|
Project plans being developed, work will be initiated through CRO. |
|||||||||
| Product Name: | HIV | ||||||||
| Therapeutic Area: | Small Molecule | ||||||||
| Status: |
|
||||||||
|
Project plans being developed, work will be initiated through CRO. |
|||||||||